Aethlon Medical (NASDAQ:AEMD) posted its quarterly earnings results on Tuesday. The medical equipment provider reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.05), MarketWatch Earnings reports.

Shares of NASDAQ AEMD opened at $1.59 on Friday. The company has a 50-day moving average price of $2.00 and a 200-day moving average price of $1.90. The stock has a market capitalization of $24.14 million, a P/E ratio of -0.35 and a beta of 0.62. Aethlon Medical has a 1 year low of $0.76 and a 1 year high of $6.89.

About Aethlon Medical

Aethlon Medical, Inc, a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals.

Recommended Story: What is a Fiduciary?

Earnings History for Aethlon Medical (NASDAQ:AEMD)

Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with's FREE daily email newsletter.